| Elcatonin Group | Placebo Group | Difference | ||
|---|---|---|---|---|
| p Value | 95% CI | |||
| Number of participants | 17 | 15 | ||
| Age (years) | 71.5 ± 2.2 | 72.7 ± 2.1 | 0.688 | -7.4, 5.0 |
| BMD at lumbar spine (g/cm2) | 0.751 ± 0.029 | 0.660 ± 0.048 | 0.119 | -0.025, 0.207 |
| Serum BAP (U/L) | 30.8 ± 3.1 | 33.8 ± 3.0 | 0.497 | -11.8, 5.9 |
| Urinary NTx (nmol BCE/mmol Cr) | 71.6 ± 11.4 | 59.5 ± 7.5 | 0.381 | -15.8, 40.1 |